How the minefield that is socia media could actually prove beneficial for the world of pharma.
Drug repositioning – a key tool in the drug development arsenal
Drug development pipelines have been a major indicator of the health of the pharmaceutical industry itslef. However if we look at recent trends, the simple truth is that many company pipelines are drying up and most are not growing at the desired pace. By Biovista
Key account management
Eight questions on key account management with Nev Skelton of IMS Health
Standing out from the crowd
Mike Cola and Sylvie Gregoire of Shire Pharmaceuticals explain why being different is increasingly important in the dark days of economic recession. By Natalie Brandweiner
Patient power
Millennium’s Isabelle Mercier tells NGP about the rising power of patient influence and marketing’s delivery of information demand.
Sink or swim
The global financial crisis has prompted a rash of mergers, consolidations and layoffs in the pharmaceutical sector. Will the European industry stay afloat in these challenging times? By Marie Shields
Source: www.ngpharma.eu.com© 2012 GDS Publishing Ltd. All rights reserved.